272 related articles for article (PubMed ID: 10600635)
1. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
4. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
5. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
Smith DK; Treutlein HR
Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
[TBL] [Abstract][Full Text] [Related]
6. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
7. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
8. Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells.
Giese B; Roderburg C; Sommerauer M; Wortmann SB; Metz S; Heinrich PC; Müller-Newen G
J Cell Sci; 2005 Nov; 118(Pt 21):5129-40. PubMed ID: 16254248
[TBL] [Abstract][Full Text] [Related]
9. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
Yamanaka Y; Nakajima K; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Apr; 15(7):1557-65. PubMed ID: 8612579
[TBL] [Abstract][Full Text] [Related]
10. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130.
Kurth I; Horsten U; Pflanz S; Timmermann A; Küster A; Dahmen H; Tacken I; Heinrich PC; Müller-Newen G
J Immunol; 2000 Jan; 164(1):273-82. PubMed ID: 10605021
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
[TBL] [Abstract][Full Text] [Related]
12. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
[TBL] [Abstract][Full Text] [Related]
13. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor.
Hammacher A; Richardson RT; Layton JE; Smith DK; Angus LJ; Hilton DJ; Nicola NA; Wijdenes J; Simpson RJ
J Biol Chem; 1998 Aug; 273(35):22701-7. PubMed ID: 9712900
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
Chakraborty A; Guha S
Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
[TBL] [Abstract][Full Text] [Related]
15. CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain.
Gregg C; Weiss S
Development; 2005 Feb; 132(3):565-78. PubMed ID: 15634701
[TBL] [Abstract][Full Text] [Related]
16. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
17. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
18. Structure of an extracellular gp130 cytokine receptor signaling complex.
Chow D; He X; Snow AL; Rose-John S; Garcia KC
Science; 2001 Mar; 291(5511):2150-5. PubMed ID: 11251120
[TBL] [Abstract][Full Text] [Related]
19. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.
Viswanathan S; Benatar T; Rose-John S; Lauffenburger DA; Zandstra PW
Stem Cells; 2002; 20(2):119-38. PubMed ID: 11897869
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.
Haan C; Heinrich PC; Behrmann I
Biochem J; 2002 Jan; 361(Pt 1):105-11. PubMed ID: 11742534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
